The Hennessy Institute for Cancer Prevention and Applied Molecular Medicine will utilize CancerIQ’s AI platform for personalized risk assessments and advanced early detection.
from MobiHealthNews https://ift.tt/mCHMpyi
https://ift.tt/JpHLQyG
from MobiHealthNews https://ift.tt/mCHMpyi
https://ift.tt/JpHLQyG